Moderna Inc. buy UBS Group AG
Start price
19.02.25
/
50%
€34.80
Target price
19.02.26
€74.74
Performance (%)
-18.74%
Price
29.07.25
€28.28
Summary
This prediction is currently active. The prediction for Moderna Inc. disappoints with a performance of -18.74%. This prediction currently runs until 19.02.26. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Moderna Inc. | 1.544% | 1.544% |
| iShares Core DAX® | 0.426% | 0.647% |
| iShares Nasdaq 100 | 2.809% | 4.822% |
| iShares Nikkei 225® | 3.288% | -1.311% |
| iShares S&P 500 | 2.785% | 4.737% |
Comments by UBS_Group_AG for this prediction
In the thread Moderna Inc. diskutieren
Moderna, Inc. (NASDAQ: MRNA) had its price target lowered by analysts at UBS Group AG from $96.00 to $78.00. They now have a "buy" rating on the stock.
Ratings data for MRNA provided by MarketBeat